Home > Insider Trading > Ap Pharma Inc > Profile

Ap Pharma Inc (APPA)

Sector: Pharmaceutical Preparations

Related Insiders

Robert Rosen, President, 2013-05-03
D Barry Quart, Chief Executive Officer, 2013-05-03
Stephen Davis, Chief Operating Officer, 2013-05-03

Robert Rosen, President, 2013-05-03
D Barry Quart, Chief Executive Officer, 2013-05-03
Stephen Davis, Chief Operating Officer, 2013-05-03
Md S. Mark Gelder, Svp & Chief Medical Officer, 2013-05-03
Spch, Llc, Large Shareholder, 2013-04-16
Savitr Capital, Llc, Large Shareholder, 2013-04-15
C Kevin Tang, Director, 2013-02-14
Lp Partners Capital Tang, Large Shareholder, 2013-02-14
Llc Management Capital Tang, Large Shareholder, 2013-02-14
A Michael Adam, Chief Operating Officer, 2013-02-13
John Whelan, President, Ceo And Cfo, 2013-02-13
R Andrew Midler, Large Shareholder, 2012-09-24
Paul Goddard, Director, 2012-05-31
Greg Turnbull, Director, 2012-05-31
John Barr, Vice President Of R&d, 2011-07-12
Ltd Fund Master Sciences Life Perceptive, Large Shareholder, 2011-07-07
Llc Advisors Perceptive, Large Shareholder, 2011-07-07
Julian Baker, Large Shareholder, 2011-07-06
Felix Baker, Large Shareholder, 2011-07-06
Baker Biotech Capital (Gp), Llc, Large Shareholder, 2011-07-06
Baker Brothers Life Sciences Capital (Gp), Llc, Large Shareholder, 2011-07-06
14159 Capital (Gp), Llc, Large Shareholder, 2011-07-06
Baker Bros. Capital (Gp), Llc, Large Shareholder, 2011-07-06
J Ronald Prentki, Director, 2009-07-08
Md L Robert Zerbe, Director, 2009-05-29
Toby Rosenblatt, Director, 2009-05-29

Show All Insiders (26)

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaning Holdings	Date	Form 4
Spch,	$0.53	38,095,238	Large Shareholder	38,095,238	2012-07-25	Filing
Tang	$0.88	2,443,181	Director	10,436,506	2009-10-19	Filing
Tang	$0.42	175,000	Large Shareholder	7,993,325	2008-12-31	Filing

Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 20 percentage points in 6 months - Learn how!

Hedge Fund Resource Center

Billionaire Hedge Funds